Imatinib - Dr Reddy's

Land: Neuseeland

Sprache: Englisch

Quelle: Medsafe (Medicines Safety Authority)

Wirkstoff:

Imatinib mesilate 119.47mg equivalent to imatinib 100mg

Verfügbar ab:

Dr Reddy's New Zealand Limited

INN (Internationale Bezeichnung):

Imatinib mesilate 119.47 mg (equivalent to imatinib 100mg)

Dosierung:

100 mg

Darreichungsform:

Capsule

Zusammensetzung:

Active: Imatinib mesilate 119.47mg equivalent to imatinib 100mg Excipient: Crospovidone Gelatin Iron oxide red Iron oxide yellow Sodium laurilsulfate Sodium stearyl fumarate Tekprint red SB-1033 Titanium dioxide Water

Verschreibungstyp:

Prescription

Hergestellt von:

Hetero Labs Limited

Anwendungsgebiete:

Treatment of adult and paediatric patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukaemia (Ph+CML). Treatment of adult and paediatic patients with Ph+CML in blast crisis, accelerated phase, or in chronic phase after failure of interferon-alpha therapy.

Produktbesonderheiten:

Package - Contents - Shelf Life: Blister pack, PVC/ Aclar or Aluminium/Aluminium - 60 capsules - 24 months from date of manufacture stored at or below 25°C protect from moisture

Berechtigungsdatum:

2014-06-30